Genpact director granted 6,521 RSUs

Genpact LTD director Carol Lindstrom received an equity award of 6,521 common-share RSUs.

Rhea-AI Filing Summary

Genpact LTD director Carol Lindstrom received an equity award of 6,521 common-share RSUs. The grant, priced at $0.00 per unit as compensation, increases her direct holdings to 27,706 common shares after the award. Each restricted share unit entitles her to one common share at a future date.

According to the award terms, all RSUs will fully vest on December 31, 2026, assuming she continues in service, and will be settled in common shares on December 31, 2027. This is a non-market, compensation-related acquisition rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider Lindstrom Carol

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 27,706 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSUs granted: 6,521 units Grant price: $0.00 per share Shares after grant: 27,706 shares +2 more

5 metrics

RSUs granted 6,521 units Restricted share units awarded to director on April 23, 2026

Grant price $0.00 per share Compensation-related award, not open-market purchase

Shares after grant 27,706 shares Total Genpact common shares held directly after transaction

Vesting date December 31, 2026 RSUs fully vest subject to continued service

Settlement date December 31, 2027 RSUs settled in common shares on this date

Key Terms

restricted share units (RSUs), 2017 Omnibus Incentive Compensation Plan, vest, settled in common shares

4 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

2017 Omnibus Incentive Compensation Plan financial

"RSUs granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

vest financial

"Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

settled in common shares financial

"and will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) director Carol Lindstrom report in this Form 4?

Carol Lindstrom reported receiving 6,521 restricted share units (RSUs) of Genpact common shares as a compensation award. The grant is a non-cash, non-market acquisition and increases her direct holdings to 27,706 common shares after the transaction.

How many Genpact (G) shares does Carol Lindstrom hold after this RSU grant?

After the RSU grant, Carol Lindstrom directly holds 27,706 Genpact common shares. This total includes the effect of the 6,521 newly awarded restricted share units reported in the filing as a grant, award, or other acquisition transaction.

Are Carol Lindstrom’s new Genpact (G) RSUs immediately vested or tradable?

The 6,521 Genpact RSUs are not immediately vested or tradable. Subject to her continued service, they fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027, delaying actual share delivery until that settlement date.

What plan governs the RSU award to Genpact (G) director Carol Lindstrom?

The RSU award to Carol Lindstrom was granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. This plan allows the company to issue restricted share units, each of which converts into one common share at a specified future settlement date.

Is Carol Lindstrom’s Genpact (G) RSU award an open-market purchase or a compensation grant?

The 6,521 Genpact RSUs reported by Carol Lindstrom are a compensation-related grant, not an open-market purchase. The transaction code is “A,” described as a grant, award, or other acquisition, with a price of $0.00 per share in the filing.

When will Carol Lindstrom receive Genpact (G) common shares from this RSU grant?

Carol Lindstrom’s RSUs will fully vest on December 31, 2026, assuming continued service, and will be settled in Genpact common shares on December 31, 2027. At settlement, each restricted share unit converts into one common share delivered to her.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:25 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindstrom Carol

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	27,706	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Carol Lindstrom	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)